Key result
Newly diagnosed Graves' disease is associated with higher 24-h pulse wave velocity compared to euthyroid controls (adjusted difference 1.0 m/s; 95% CI 0.6-1.5).
Why the study?
Excess cardiovascular morbidity and mortality in hyperthyroidism and Graves disease is inadequately understood.
Does newly diagnosed Graves' disease increase arterial stiffness and blood pressure compared to euthyroid controls?
Cross-Sectional (n=110)
Does newly diagnosed Graves' disease increase arterial stiffness and blood pressure compared to euthyroid controls?
Newly diagnosed Graves' disease is associated with higher 24-hour pulse wave velocity and pulse pressure compared to euthyroid controls, suggesting increased arterial stiffness.
Answers are grounded in this paper and cite their sources.
Graves' disease may increase arterial stiffness; cross-sectional association leaves open causality and need for outcome trials.
INTRODUCTION AND OBJECTIVE: The excess cardiovascular morbidity and mortality in hyperthyroidism and Graves' disease (GD) is inadequately understood. We aimed to elucidate whether well-established cardiovascular risk factors such as arterial stiffness in terms of pulse wave velocity (PWV) and blood pressure differ in GD and controls. METHODS: This was a cross-sectional study comparing 55 hyperthyroid patients with newly diagnosed GD and 55 euthyroid, population-based controls matched for age, sex and menopausal status. PWV and blood pressure were measured in office (SphygmoCor Xcel) and 24-h ambulatory settings (Arteriograph). Differences between groups were assessed using adjusted linear regression analysis. RESULTS: Compared to controls, GD patients showed higher PWV in the 24-h but not in the office setting with an adjusted 24-h PWV difference of 1.0 (95% CI: 0.6-1.5) m/s. PWV was higher in GD at both day and night, and nightly PWV dipping was lower (-5.5, 95% CI: -10.4 to -0.6%). Furthermore, central and brachial pulse pressure was significantly higher in both the office and 24-h setting, whereas nightly central pulse pressure dipping was significantly lower in GD (-5.4, 95% CI: -10.5 to -0.2%). Mean arterial pressure did not differ between the groups. CONCLUSIONS: Despite comparable blood pressure, GD is associated with a higher 24-h PWV that was not detected in the office setting. Pulse pressure was higher in GD, whereas mean arterial pressure did not differ between the groups. Longitudinal studies should pursue whether higher PWV might be a piece to the puzzle of understanding the increased risk of cardiovascular disease in hyperthyroidism and GD.
No takes yet. Share an insight, caveat, or question.
Grove‐Laugesen et al. (2020) conducted a cross-sectional in Graves' disease (n=110). Graves' disease vs. Euthyroid controls was evaluated on 24-h pulse wave velocity (PWV) (MD 1.0, 95% CI 0.6-1.5). Newly diagnosed Graves' disease is associated with higher 24-h pulse wave velocity compared to euthyroid controls (adjusted difference 1.0 m/s; 95% CI 0.6-1.5).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: